CTD Holdings, Inc. (OTCMKTS:CTDH)’s stock price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.33 and traded as low as $0.22. CTD shares last traded at $0.22, with a volume of 37,500 shares.
The business’s 50 day moving average is $0.33 and its 200 day moving average is $0.55.
CTD (OTCMKTS:CTDH) last issued its quarterly earnings data on Wednesday, May 15th. The biotechnology company reported ($0.02) EPS for the quarter. The business had revenue of $0.22 million during the quarter. CTD had a negative return on equity of 1,504.86% and a negative net margin of 516.52%.
CTD Holdings, Inc, a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.
See Also: What is insider trading?
Receive News & Ratings for CTD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CTD and related companies with MarketBeat.com's FREE daily email newsletter.